Navigation Links
Boehringer Ingelheim and Ashoka Changemakers Launch Competition to Find Business Models that Transform Health Systems
Date:1/24/2013

WASHINGTON and INGELHEIM, Germany, Jan. 24, 2013 /PRNewswire-USNewswire/ -- Boehringer Ingelheim and Ashoka Changemakers are launching Transforming Health Systems: Gamechanging Business Models, an online competition to discover innovative business models that are solving critical problems in health systems around the world.

"Traditional healthcare systems in mature markets are not designed to encourage enough collaboration between key players, such as care providers, insurance companies, and government organizations," said Jean Scheftsik de  Szolnok, Vice-President Southern Europe for Boehringer Ingelheim and Making More Health Steering Committee Chair. "Often, the systems' misaligned incentives fail to produce real value for patients and society. Innovative business models are urgently needed to solve this issue."

Transforming Health Systems also seeks business models that confront problems in emerging markets where governments, businesses, and non-profits often lack the resources or commitment to serve communities in need.

Winners will receive awards totaling US $85,000 plus support from Boehringer Ingelheim to help advance their business models. They will be matched with Boehringer Ingelheim's local country offices, and will be able to explore the potential for partnerships or further on-going support. All individuals, organizations, or partnerships are eligible to enter from now until April 10, 2013 at changemakers.com/healthbiz.

Transforming Health Systems was built on key insights gained from the first Making More Health competition launched by Boehringer Ingelheim and Ashoka Changemakers.

"The previous Making More Health competition added tremendously to Ashoka's network of social entrepreneurs who are working to solve the critical problems plaguing the world's
'/>"/>

SOURCE Ashoka Changemakers
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
(Date:5/16/2013)... Inc. (NYSE: ALR ), a global leader in ... through the merger of rapid diagnostics and health management, has ... Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend ... of Series B stock at the close of business on ... amount of all dividends accrued from April 1, 2013 through ...
(Date:5/16/2013)... ADDISON, Texas , May 16, 2013  ULURU Inc. ... quarter ended March 31, 2013 and provided a review of ... activities, the Company is confirming the previously communicated outlook for ... markets; , Expanding the network of distribution partners to ... and , Positioning Altrazeal ® to be marketed ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
... the battle is ... far from won, ... patients with blood cancers. Sixty years ago there,were few effective treatments for ... low. Today, about 75 percent of children with,acute leukemia and nearly 80 ...
... Fla., Sept. 12 Once every two hours a,Florida ... skin cancer,according to the American Cancer Society. A local ... the likelihood that local,residents diagnosed with this deadliest type ... the sun or protecting your skin from harmful,ultraviolet rays ...
Cached Medicine Technology:September is Leukemia, Lymphoma and Myeloma Awareness Month 2Saving Lives of Florida Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment 2
(Date:5/18/2013)... 18, 2013) The use of a smartphone ... according to new research presented today at Digestive ... days in advance of the procedure, includes dietary ... be taken at strict intervals. The better the ... see cancer and precancerous polyps in the colon. ...
(Date:5/18/2013)... 2013) A ground-breaking advance in colonoscopy technology ... research presented today at Digestive Disease Week (DDW). ... time for colonoscopies and exploring safer methods for ... use a device called a colonoscope to examine ... allows a doctor to look for precancerous polyps ...
(Date:5/18/2013)... 18, 2013 The “World Healthcare IT ... studies the major market drivers, restraints, and opportunities in ... , Browse , 89 market ... TOC on "Healthcare IT Market" , ... on reports. , The global healthcare IT market is ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 During Better ... loss should consider the legal protections they have, including ... problems arise with their child’s treatment or hearing aid ... Since 1927, the American Speech-Language-Hearing Association has used the ... and to promote treatment, such as cochlear implants, which ...
(Date:5/18/2013)... Florida (PRWEB) May 18, 2013 Adolescents, ... also known as “Spice” or “K2” are landing in ... helping to curb this drug epidemic with a ... synthetic marijuana. , According to research from the National ... second-most popular illegal drug among American teenagers. In 2012, ...
Breaking Medicine News(10 mins):Health News:New smartphone application improves colonoscopy preparation 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2
... Nelson is proud to announce the launch of the ... new AR Nelson site is designed to provide a ... to hospitals, operating facilities and clinics in the medical ... IV track, IV bottle holders, or carriers and hardware, ...
... injury attorney Mark E. Seitelman announces a major website re-design, ... and Plain English. , ... New ... Mark E. Seitelman announces a major website re-design, aimed specifically ...
... Center and its neighbor eight miles to the ... one in a survey by the Centers for ... satisfaction" in the states of Idaho and Washington, ... the hospitals also partner on physician recruitment and ...
... law firm representing families of individuals who suffered from suicidal ... , ... Mineola, N.Y. (Lexis Nexis) ... partner of leading national personal injury law firm Sanders Viener ...
... 5 Banque Centrale Populaire,(BCP), one of the ... offer to corporates with the new trade finance ... company., The extension of the longstanding partnership ... the latest version of Misys Trade,Innovation and benefit ...
... Today the United States,Patent & Trademark Office ... process that eliminates the effects of a broad ... for abating pollutants,bacteria, viruses, mold, dander and dust ... smoke odors. In contrast with previous processes,there is ...
Cached Medicine News:Health News:AR Nelson Launches New Optimized Website 2Health News:AR Nelson Launches New Optimized Website 3Health News:Re-Designed Legal Website Includes Blog 2Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 2Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 3Health News:New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs 2Health News:Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys 2Health News:USPTO Issues Patent Embodying Methodologies for Abating a Broad Range of Allergens, Pathogens, Viruses, Bacteria, Odors and Volatile Organic Compounds. 2
... clinical assistant that integrates technology from ... in the C5 allows you to ... your,shift such as administer medication, record ... one single device.,With Intel® Centrino® mobile ...
Colloidal Gold Conjugated, Streptavidin - 12 OD...
Custom Conjugation Services...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Medicine Products: